Shao Mu Guo
Direktor/Vorstandsmitglied bei YIDA CHINA HOLDINGS LIMITED
Aktive Positionen von Shao Mu Guo
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| YIDA CHINA HOLDINGS LIMITED | Direktor/Vorstandsmitglied | 01.06.2014 | - |
| Independent Dir/Board Member | 01.06.2014 | - | |
| GALAXYCORE INC. | Direktor/Vorstandsmitglied | 23.01.2014 | - |
| Independent Dir/Board Member | 23.01.2014 | - | |
| FANTASIA HOLDINGS GROUP CO., LIMITED | Direktor/Vorstandsmitglied | 01.02.2015 | - |
| Independent Dir/Board Member | 01.02.2015 | - | |
| SUNKWAN PROPERTIES GROUP LIMITED | Direktor/Vorstandsmitglied | 27.10.2020 | - |
| Independent Dir/Board Member | 27.10.2020 | - | |
| SHANGHAI HEARTCARE MEDICAL TECHNOLOGY CORPORATION LIMITED | Direktor/Vorstandsmitglied | 23.11.2020 | - |
| Independent Dir/Board Member | 23.11.2020 | - | |
MicuRx Pharmaceuticals, Inc.
 MicuRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology MicuRx Pharmaceuticals, Inc. is a holding company, which engages in the discovery, development, and commercialization of safe and effective antimicrobial therapeutics for multidrug-resistant superbag infections. The company was founded by Zheng Yu Yuan and Mikhail Fedorovich Gordeev in March 2007 and is headquartered in Pudong, China. | Direktor/Vorstandsmitglied | 01.01.2018 | - |
| Independent Dir/Board Member | 01.01.2018 | - | |
Shanghai Xinwei Medical Technology Co., Ltd.
 Shanghai Xinwei Medical Technology Co., Ltd. BiotechnologyHealth Technology Shanghai Xinwei Medical Technology Co., Ltd. develops products for the prevention and treatment of stroke. The company is based in Shanghai, China. The Chinese company was founded in 2016 by Guo Hui Wang, who has been the CEO since 2016. | Direktor/Vorstandsmitglied | - | - |
| Independent Dir/Board Member | - | - |
Karriereverlauf von Shao Mu Guo
Ehemalige bekannte Positionen von Shao Mu Guo
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| GANGLONG CHINA PROPERTY GROUP LIMITED | Direktor/Vorstandsmitglied | 01.06.2020 | 01.12.2023 |
| Independent Dir/Board Member | 01.06.2020 | 01.12.2023 | |
Morgan Stanley Asia Ltd.
 Morgan Stanley Asia Ltd. Investment Banks/BrokersFinance Morgan Stanley Asia Ltd. (MSA) is a broker/dealer headquartered in Hong Kong. The firm was founded in 1987 and is a subsidiary of Morgan Stanley (NYSE: MS) in the US. MSA provides institutional securities such as equities, fixed income, derivatives and research. | Corporate Officer/Principal | 01.04.2007 | 01.04.2013 |
| ░░░░░░░░ ░░░░░ ░░░░ ░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░ ░░░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░ ░░░░░░░░ ░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Ausbildung von Shao Mu Guo
| University of Southern California | Graduate Degree |
| Zhejiang University | Undergraduate Degree |
| Yale School of Management | Masters Business Admin |
Statistik
International
| China | 9 |
| Hong Kong | 7 |
| Vereinigte Staaten | 4 |
Operativ
| Director/Board Member | 10 |
| Independent Dir/Board Member | 8 |
| Corporate Officer/Principal | 6 |
Sektoral
| Finance | 8 |
| Consumer Services | 4 |
| Health Technology | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 6 |
|---|---|
| FANTASIA HOLDINGS GROUP CO., LIMITED | Finance |
| YIDA CHINA HOLDINGS LIMITED | Finance |
| GANGLONG CHINA PROPERTY GROUP LIMITED | Finance |
| SUNKWAN PROPERTIES GROUP LIMITED | Finance |
| SHANGHAI HEARTCARE MEDICAL TECHNOLOGY CORPORATION LIMITED | Health Technology |
| GALAXYCORE INC. | Electronic Technology |
| Private Unternehmen | 10 |
|---|---|
MicuRx Pharmaceuticals, Inc.
MicuRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology MicuRx Pharmaceuticals, Inc. is a holding company, which engages in the discovery, development, and commercialization of safe and effective antimicrobial therapeutics for multidrug-resistant superbag infections. The company was founded by Zheng Yu Yuan and Mikhail Fedorovich Gordeev in March 2007 and is headquartered in Pudong, China. | Health Technology |
| Salomon Smith Barney, Inc. | Finance |
| HSBC Markets Asia Ltd. | |
| HSBC Investment Asia Holdings Ltd. | |
Morgan Stanley Asia Ltd.
Morgan Stanley Asia Ltd. Investment Banks/BrokersFinance Morgan Stanley Asia Ltd. (MSA) is a broker/dealer headquartered in Hong Kong. The firm was founded in 1987 and is a subsidiary of Morgan Stanley (NYSE: MS) in the US. MSA provides institutional securities such as equities, fixed income, derivatives and research. | Finance |
JPMorgan Chase Bank (China) Co. Ltd.
 JPMorgan Chase Bank (China) Co. Ltd. Regional BanksFinance Part of JPMorgan Chase & Co., JPMorgan Chase Bank (China) Co. Ltd. is a Chinese company that offers trade finance, cash management, and commercial banking. The company is based in Beijing, China. | Finance |
| Citigroup Global Markets China Ltd. | |
Shanghai Xinwei Medical Technology Co., Ltd.
Shanghai Xinwei Medical Technology Co., Ltd. BiotechnologyHealth Technology Shanghai Xinwei Medical Technology Co., Ltd. develops products for the prevention and treatment of stroke. The company is based in Shanghai, China. The Chinese company was founded in 2016 by Guo Hui Wang, who has been the CEO since 2016. | Health Technology |
| Ljmjl Advisors Hk Ltd. | |
| Mjl Fun Ltd. |
- Börse
- Insiders
- Shao Mu Guo
- Erfahrung
